Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,540,370 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
The present invention relates to novel heterocyclic compounds of formula I ##STR00001## wherein the variables are as defined in the claims or the description,...
US-9,540,369 Use of kinase inhibitors to increase the susceptibility of gram positive bacteria to beta lactam antibiotics
Methods of using certain kinase inhibitors for treating Gram positive bacterial infections are disclosed. When co-administered with a .beta.-lactam antibiotic,...
US-9,540,368 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3,...
US-9,540,367 Deuterated baricitinib
The present invention in one embodiment provides a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the variables...
US-9,540,366 Ring-fused heterocyclic compound
The ring-fused heterocyclic compound or a pharmaceutically acceptable salt thereof according to the present invention has a T-type calcium channel regulatory...
US-9,540,365 Compounds for bone growth
In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of...
US-9,540,364 Benzimidazole tetrahydrofuran derivatives
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases...
US-9,540,363 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
The present disclosure relates to crystalline form of (S)--N--((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-py- ...
US-9,540,362 Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions...
The present invention relates to novel compounds of Formula 1 as sphingosine-1-phosphate receptor agonists which can be effectively used for the treatment of...
US-9,540,361 N-substituted azetidine derivatives
The present invention relates to novel N-substituted azetidine derivatives < of the formula (I); wherein SERMF is a Selective Estrogen Receptor Modilator...
US-9,540,360 Sulfonamide compounds having TRPM8 antagonistic activity
Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a...
US-9,540,359 Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity
The present invention provides a compound which has an effect of inhibiting amyloid .beta. production, especially an effect of inhibiting BACE1, and which is...
US-9,540,358 Tricyclic compounds as anticancer agents
Tricyclic chemical modulators of FOXO transcription factor proteins are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity,...
US-9,540,357 15-aryl prostaglandins as EP4 agonists, and methods of use thereof
The invention provides compositions and methods for reducing healing wounds and reducing scars and blemishes. The compositions and methods of the invention...
US-9,540,356 Compounds having a protective activity against toxins with intracellular activity
The present invention concerns a new family of 2,3-dihydroquinazolin-4(1H)-one compounds of general formula (I), and the use thereof as inhibitors of the toxic...
US-9,540,355 Irciniastatin analogues
The present invention is directed to irciniastatin analogs. Uses of these analogs also described.
US-9,540,354 Diamide inhibitors of cytochrome P450
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other...
US-9,540,353 SHIP1 modulators and methods related thereto
Compounds of formula (I): where, n, R.sup.1, R.sup.4a, R.sup.4b, R.sup.5, R.sup.7 and R.sup.8 are defined herein, or pharmaceutically acceptable salts thereof,...
US-9,540,352 Substituted 1,7-naphthyridines as dopamine D1 ligands
The present invention provides, in part, compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof; processes for the preparation of;...
US-9,540,351 Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
Provided herein are pharmaceutically acceptable salts of 3,5-diaminopyrazoles, for example, pharmaceutically acceptable salts of compounds of Formula IA, that...
US-9,540,350 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods...
Disclosed herein are novel antifungal compounds of Formula 1, containing 1-substituted, 4-(substituted phenoxy-methyl)-1,2,3-triazole moieties coupled to a core...
US-9,540,349 Substituted pyrimidine compounds
The invention relates to novel substituted pyrimidine compounds of general formula (I) ##STR00001## in which the chemical groupings, substituents, variables...
US-9,540,348 Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereof, and pharmaceutic composition...
The present invention relates to a novel imidazole-1-yl pyrimidine derivative, a pharmaceutically acceptable salt thereof, and a pharmaceutic composition...
US-9,540,347 Pyridineamine compounds useful as Pim kinase inhibitors
The present disclosure describes pyridineamine compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim...
US-9,540,346 Sovaprevir polymorphs and methods of manufacture thereof
The disclosure provides crystalline Sovaprevir forms. The crystalline forms of Sovaprevir comprise a Form A polymorph, a Form B polymorph, a Form C polymorph, a...
US-9,540,345 Antiviral compounds
The present invention discloses compounds of Formula (I): wherein the variables in Formula (I) are defined as described herein. Also disclosed are...
US-9,540,344 Production method for isoquinoline derivatives and salts thereof
The present invention provides a method capable of industrially producing a target product, i.e., a compound represented by the aforementioned formula (I) or a...
US-9,540,343 Compounds for the treatment of HIV
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a...
US-9,540,342 Processes for the preparation of pesticidal compounds
The present application provides processes for making pesticidal compounds and compounds useful both as pesticides and in the making of pesticidal compounds.
US-9,540,341 Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
The invention relates to novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione, including a novel urea cocrystal of...
US-9,540,340 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions...
The invention provides 3-deuterium-enriched 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers...
US-9,540,339 Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and...
A resist composition containing a compound represented by the general formula (1) or (2), a method for forming a resist pattern using the composition, a...
US-9,540,338 Substituted cinnamic acid amides for treating pain
A cinnamic acid amide derivative having an excellent analgesic action is disclosed herein. The cinnamic acid amide derivative shows excellent analgesic actions...
US-9,540,337 Gamma-glutamyl transpeptidase inhibitors and methods of use
Compositions that are effective in inhibiting gamma-glutamyl transpeptidase are disclosed. Methods of producing and using these compositions are also disclosed.
US-9,540,336 Therapeutic agents
The present invention includes a method of treating or preventing a disease or disorder such as a mycobacterial infection, a Gram-positive bacterium infection,...
US-9,540,335 Salts of an epidermal growth factor receptor kinase inhibitor
The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable...
US-9,540,334 2,4-pyrimidinediamine compounds and their uses
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical...
US-9,540,333 Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFN.alpha.
Compounds having the following formula (I): or a stereoisomer or pharmaceutically-acceptable salt thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5...
US-9,540,332 Benzimidazole derivatives as selective blockers of persistent sodium current
The present invention is directed to a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof; wherein R, R.sup.1, R.sup.2, R.sup.3,...
US-9,540,331 Preparation method of dexmedetomidine intermediate
The present invention discloses a preparation method of 2,3-dimethyl phenyl-1-trityl-imidazole-4-ketone. In accordance with this method, imidazole-4-ethyl...
US-9,540,330 Oligomer-containing hydantoin compounds
The invention relates to (among other things) oligomer-containing hydantoin compounds. A compound of the invention, when administered by any of a number of...
US-9,540,329 Organic electroluminescent materials and devices
Heteroleptic complexes having at least one diarylamino or carbazole group, as shown in Formula (I), are provided: ##STR00001## wherein R.sub.1, R.sub.2,...
US-9,540,328 (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-on- e (L)-(+) tartrate salt, its method...
The present invention is directed to (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-o- ne (L)-(+) tartrate salt, a pharmaceutical...
US-9,540,327 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Provided are bis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine receptors. Also provided are methods of using the compounds for...
US-9,540,326 Prolyl hydroxylase inhibitors
Disclosed herein are prolyl hydroxylase inhibitors that can stabilize hypoxia inducible factor-1 alpha (HIF-1.alpha.), as well as hypoxia inducible factor-2...
US-9,540,325 N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical...
An N1-cyclic amine-N5-substituted phenyl biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same,...
US-9,540,324 Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods...
US-9,540,323 7-hydroxy-indolinyl antagonists of P2Y.sub.1 receptor
The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds....
US-9,540,322 MIF modulators
The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat...
US-9,540,321 Process for large scale production of ...
A process suitable for adoption to large scale manufacture of 1-[(2-bromophenyl-sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-- 1H-indole dimesylate...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.